A Pilot Study of Safety, Tolerability, and Immunological Effects of SurVaxM in Pediatric Patients with Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Is this Study for You?

Let's Get Started!


Child to Adult


Childrens Hospital Colorado

Principal Investigator
Photograph of Kathleen Dorris

Kathleen Dorris

Study ID

Protocol Number: 22-0490

More information available at ClinicalTrials.gov: NCT04978727


Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers